Evidence map›Paper›PMID 23633947›Full record

ArticlePLoS pathogens2013

Have it your way: how polymorphic, injected kinases and pseudokinases enable Toxoplasma to subvert host defenses.

John C Boothroyd

Abstract read
In one paragraph

Article in PLoS pathogens, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Released Parasite-Derived Kinases as Novel Targets for Antiparasitic Therapies.Frontiers in cellular and infection microbiology · 2022
    Review
  4. Protein kinases in Toxoplasma gondii.International journal for parasitology · 2021
    Review
  5. Article
  6. Article
  7. Divergent kinase regulates membrane ultrastructure of theProceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  8. The coccidian parasitesThe Journal of biological chemistry · 2017
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

John C BoothroydDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA. jboothr@stanford.edu

Funding

Toxoplasma Rhoptry FunctionR01AI021423 · NIAID · STANFORD UNIVERSITY · PI BOOTHROYD, JOHN C · 1985 to 2018
$7.8M
Strain-specific Host-Pathogen Interactions in ToxoplasmosisR01AI073756 · NIAID · STANFORD UNIVERSITY · PI BOOTHROYD, JOHN C · 2007 to 2016
$4.2M
NIAID NIH HHS R01 AI021423NIAID NIH HHS R01 AI073756NIAID NIH HHS R01-AI21423NIAID NIH HHS R01-AI73756
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Host-Parasite InteractionsHumansProtein Serine-Threonine KinasesProtein-Tyrosine KinasesProtozoan ProteinsToxoplasmaToxoplasmosisVirulence FactorsProtein Serine-Threonine KinasesProtein-Tyrosine KinasesProtozoan ProteinsRop16 protein, Toxoplasma gondiiROP18 protein, Toxoplasma gondiiVirulence Factors

Identifiers

PMID23633947
PMCPMC3635977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.